Cerebral palsy (CP) is considering as a non-progressive neuromotor disorder of cerebral origin. It includes heterogeneous clinical states of variable etiology and severity ranging from minor incapacitation to total handicap. In India 1.77% of the population has some form of disability. Spastic cerebral palsy is most common and incidence is 60% to 70% of all cerebral palsy case. It cannot be correlated with any single disease or condition in Ayurveda, as it is a multi-factorial disease with clinical features of a wide variation. It can be taken as Vatavyadhi as far as its etiology and symptoms are concerned. Here, an effort was made to treat a 5-year-old male child with spastic diplegic. Cerebral Palsy using multiple Ayurvedic treatment modalities. 3 Month oral medicine and Pañcakarma procedures resulted in better improvement in sign and symptom of cerebral palsy.
Introduction: Amlapittadescribed in Ayurvedaclassics resembles to the clinical features of GERD.Amlapittais more prevalent disease ofAnnavaha Srotasa(gastrointestinal system) described in various classicalAyurvedictexts.Narikela Khandaand Kushmanda Khandaare the formulations mentioned in Bhaisajya Ratnavaliindicated for management of Amlapitta. Aims:To evaluate the effect of NarikelaKhanda and KushmandaKhanda in management of Amlapitta. Materials and methods: A non-randomized, single-armed, open-labeled clinical trial was conducted in 30 patients having classical symptoms ofAmlapitta,administered with 10gm ofNarikela Khanda & 10gmof Kushmanda Khandatwice a day after food for 30 days respectively. The assessment was done based on subjective parameters, i.e., Amlodgara(sourbelching),Daha(heartburn),Gaurava(heaviness),Utklesha(nausea),Avipaka(indigestion) andAruchi(loss of appetite) were taken into consideration. The subjective parameters were analysed by Wilcoxon-W test and p-value. Result-In Group A, 6.67% patients had marked improvement, while 73.33% patients had moderate improvement and 20.00% mildly improved. In Group B, 60.00% patients had moderate improvement and 40% marked improved. In both the Group the result was statistically significant, but improvement was noticed more in Group-B. Conclusion-On comparison between two groups, Kushmanda Khandahave shown more effect than Narikela Khanda.No adverse effects were noticed during clinical trial in both groups
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.